These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10480752)

  • 1. Vaccination against Lyme borreliosis.
    Wahlberg P
    Ann Med; 1999 Aug; 31(4):233-5. PubMed ID: 10480752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
    Fikrig E; Telford SR; Wallich R; Chen M; Lobet Y; Matuschka FR; Kimsey RB; Kantor FS; Barthold SW; Spielman A; Flavell RA
    J Exp Med; 1995 Jan; 181(1):215-21. PubMed ID: 7807004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
    Wressnigg N; Barrett PN; Pöllabauer EM; O'Rourke M; Portsmouth D; Schwendinger MG; Crowe BA; Livey I; Dvorak T; Schmitt B; Zeitlinger M; Kollaritsch H; Esen M; Kremsner PG; Jelinek T; Aschoff R; Weisser R; Naudts IF; Aichinger G
    Clin Vaccine Immunol; 2014 Nov; 21(11):1490-9. PubMed ID: 25185574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
    Grosenbaugh DA; Rissi DR; Krimer PM
    Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection.
    Hanson MS; Cassatt DR; Guo BP; Patel NK; McCarthy MP; Dorward DW; Höök M
    Infect Immun; 1998 May; 66(5):2143-53. PubMed ID: 9573101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.
    Gern L; Rais O; Capiau C; Hauser P; Lobet Y; Simoen E; Voet P; Pêtre J
    Immunol Lett; 1994 Mar; 39(3):249-58. PubMed ID: 8034340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT; Rose CD; Budd SM; Gibney KM
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis.
    Dunne M; al-Ramadi BK; Barthold SW; Flavell RA; Fikrig E
    Infect Immun; 1995 Apr; 63(4):1611-4. PubMed ID: 7890431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.
    Lovrich SD; Callister SM; DuChateau BK; Lim LC; Winfrey J; Day SP; Schell RF
    Infect Immun; 1995 Jun; 63(6):2113-9. PubMed ID: 7768589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for vaccine synergy between Borrelia burgdorferi decorin binding protein A and outer surface protein A in the mouse model of lyme borreliosis.
    Hanson MS; Patel NK; Cassatt DR; Ulbrandt ND
    Infect Immun; 2000 Nov; 68(11):6457-60. PubMed ID: 11035759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC.
    Zhong W; Gern L; Stehle T; Museteanu C; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1999 Mar; 29(3):946-57. PubMed ID: 10092099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of antibody responses to outer surface protein (Osp)A and OspC in dogs vaccinated with Lyme disease vaccines.
    Camire AC; Hatke AL; King VL; Millership J; Ritter DM; Sobell N; Weber A; Marconi RT
    Vet J; 2021 Jul; 273():105676. PubMed ID: 34148599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.
    Sigal LH; Zahradnik JM; Lavin P; Patella SJ; Bryant G; Haselby R; Hilton E; Kunkel M; Adler-Klein D; Doherty T; Evans J; Molloy PJ; Seidner AL; Sabetta JR; Simon HJ; Klempner MS; Mays J; Marks D; Malawista SE
    N Engl J Med; 1998 Jul; 339(4):216-22. PubMed ID: 9673299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
    Probert WS; LeFebvre RB
    Infect Immun; 1994 May; 62(5):1920-6. PubMed ID: 8168958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant vaccine for Lyme disease.
    Wallich R; Kramer MD; Simon MM
    Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis.
    Klouwens MJ; Salverda MLM; Trentelman JJ; Ersoz JI; Wagemakers A; Gerritzen MJH; van der Ley PA; Hovius JW
    Vaccine; 2021 Apr; 39(18):2561-2567. PubMed ID: 33812741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination as a modality to prevent Lyme disease. A status report.
    Wormser GP
    Infect Dis Clin North Am; 1999 Mar; 13(1):135-48, vii. PubMed ID: 10198796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.